Omnicell's (NASDAQ:OMCL) stock is up by a considerable 8.6% over the past month. However, we decided to pay attention to the company's fundamentals which don't appear to give a clear sign about the ...

The latest analyst coverage could presage a bad day for Omnicell, Inc. (NASDAQ:OMCL), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a little ...

Over the past six months, Omnicell’s stock price fell to $32.30. Shareholders have lost 14.4% of their capital, which is disappointing considering the S&P 500 has climbed by 10.5%. This may have ...

It is doubtless a positive to see that the Omnicell, Inc. (NASDAQ:OMCL) share price has gained some 64% in the last three months. But that doesn't change the fact that the returns over the last three ...

It is hard to get excited after looking at Omnicell's (NASDAQ:OMCL) recent performance, when its stock has declined 2.7% over the past week. But if you pay close attention, you might find that its key ...

Omnicell’s OMCL increasing cost of production continues to hamper the company’s margin performance. Weak hospital spending trends and tough competition also pose threats. The stock currently has a ...

Many of the medications now available, as well as many still in development, are specialty drugs for complex conditions. Medication management technologies firm Omnicell wants to ensure it’s part of ...

Omnicell is still on track for a record year in revenue. The company saw quarterly EPS fall 41.3%. Omnicell cited labor issues and hospital budget cutbacks as reasons for its lowered guidance. It ...